A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

  1. Elez, E.
  2. Pericay, C.
  3. Valladares-Ayerbes, M.
  4. Bando, I.
  5. Safont, M.J.
  6. Gallego, J.
  7. Grávalos, C.
  8. Arrivi, A.
  9. Carrato, A.
  10. Conde, V.
  11. Ortiz, M.J.
  12. López, C.
  13. Alonso, B.
  14. Ruiz de Mena, I.
  15. Díaz-Rubio, E.
  16. Tabernero, J.
  17. Aranda, E.
Aldizkaria:
British Journal of Cancer

ISSN: 1532-1827,  0007-0920

Argitalpen urtea: 2019

Alea: 121

Zenbakia: 5

Orrialdeak: 378-383

Mota: Artikulua

DOI: 10.1038/S41416-019-0537-Z GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus